BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers (Methodological Surveys in Biochemistry and Analysis, 16 A). This item is unavailable.BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers (Methodological Surveys in Biochemistry and Analysis, 16 A)

#A Peptides and Other Endogenous-Type Analytes.- #A-1 Assays of peptidoglycans and specific antibodies in biological samples.- #A-2 Cyclic decapeptides in kidney.- #A-3 Analysis of protein growth factors and optimization of their separation by HPLC.- #A-4 HPLC-EC measurement of neuropeptides in biological samples.- #A-5 Determination of substance P and neurokinins by a combined HPLC/RIA procedure.- #A-6 Methods and problems in the assay of CSF for ?-endorphin and other endogenous peptides.- #A-7 The importance of defined tracers in RIA.- #A-8 The use of radioimmunoassays for cryptic regions of peptide precursors, in the study of biosynthetic mechanisms.- #A-9 Clinical assay of somatomedins by RIA.- #A-10 Immunometric approach to peptide hormone analysis.- #B CNS-Active Drugs and Their Metabolites.- #B-1 Thirty years of antipsychotic drug analysis.- #B-2 Determination of the present-day scene.- #B-3 Analytical pitfalls with tricyclic and newer antidepressants in biological samples.- #B-4 Determination of the present-day scene.- #B-5 Analysis of thioxanthenes by HPTLC, HPLC, capillary GC, and RIA.- #B-6 HPLC-EC determination of physostigmine in biological samples.- #B-7 HPLC-UV determination of substituted benzamides in biological fluids for their pharmacokinetic study.- #C Separation Technology Applicable to Various Drugs and to Enantiomers.- #C-1 Novel capillary gas-chromatographic phases applicable to drugs.- #C-2 Liquid-solid sample preparation.- #C-3 Applicability of HPLC chiral stationary phases to pharmacokinetic and disposition studies on enantiomeric drugs.- #C-4 Attempts to obtain separations of chiral anticholinergic drugs.- #D Approaches to Analyte Detection, Identification and Measurement.- #D-1 The application of high resolution proton NMR spectroscopy to the detection of drug metabolites in biological samples.- #D-2 Detection, identification and quantitative analysis of drugs by 1H NMR.- #D-3 Pre-column (HPLC) fluorescence labelling of glucuronides.- #D-4 Photodiode array HPLC detectors in metabolic profiling and other analytical screening techniques.- #D-5 A rotating filter disc alternative to photodiode array detection systems.- Analyte Index.- General Index.